ESMO 2017

2 stories · following the connections

Business

Tucatinib Data in Multiple Tumor Types Presented at the European Society for Medical Oncology (ESMO) 2017 Congress

By Nasdaq OMXSep 11, 2017, 10:00 AM UTC

Business

Cascadian Therapeutics Announces Poster Presentations on Tucatinib in Multiple Tumor Types at the European Society for Medical Oncology (ESMO) 2017 Congress

By Nasdaq OMXAug 28, 2017, 12:30 PM UTC